Safety and Efficacy of Emergent TAVI in Patients With Severe AS

Not yet recruitingOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

September 1, 2023

Study Completion Date

November 1, 2028

Conditions
Aortic Valve StenosisTranscatheter Aortic Valve ImplantationEmergencies
All Listed Sponsors
lead

Qilu Hospital of Shandong University

OTHER

NCT05528211 - Safety and Efficacy of Emergent TAVI in Patients With Severe AS | Biotech Hunter | Biotech Hunter